[Indications of antiandrogens in benign hyperplasia of the prostate].
Service d'Urologie, Hôpital Cochin, Paris.
E
E
Benassayag
D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D017373:Cyproterone Acetate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005485:Flutamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D048289:Imidazolidines; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D000726:Androgen Antagonists; D007093:Imidazoles; D048289:Imidazolidines; D017373:Cyproterone Acetate; C021277:nilutamide; D005485:Flutamide
Indications des antiandrogènes dans l'hyperplasie bénigne de la prostate.